UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
(Amendment No. )
Filed by the Registrant ☒ |
Filed by a Party other than the Registrant ☐ | |||
Check the appropriate box: |
☐ | Preliminary Proxy Statement |
☐ | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
☒ | Definitive Proxy Statement |
☐ | Definitive Additional Materials |
☐ | Soliciting Material under §240.14a-12 |
Waters Corporation
(Name of registrant as specified in its charter)
(Name of person(s) filing proxy statement, if other than the registrant)
Payment of Filing Fee (Check the appropriate box):
☒ | No fee required |
☐ | Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11 |
(1) |
Title of each class of securities to which transaction applies: | |||
(2) |
Aggregate number of securities to which transaction applies: | |||
(3) |
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined): | |||
(4) |
Proposed maximum aggregate value of transaction: | |||
(5) |
Total fee paid:
|
☐ | Fee paid previously with preliminary materials. |
☐ | Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing. |
(1) |
Amount Previously Paid: | |||
(2) |
Form, Schedule or Registration Statement No.: | |||
(3) |
Filing Party: | |||
(4) |
Date Filed: |
April 4, 2019
Dear Stockholder:
On behalf of the Board of Directors of Waters Corporation (Waters or the Company), I cordially invite you to attend the Annual Meeting of Stockholders (the Meeting) of the Company to be held at Waters Corporation, 34 Maple Street, Milford, Massachusetts 01757 on May 14, 2019 at 9:00 a.m., local time.
The notice of Meeting, the Proxy Statement and proxy card from Waters are enclosed. You may also read the notice of Meeting, the Proxy Statement and the Waters Annual Report (Annual Report) on the Internet at http://www.proxydocs.com/wat.
Waters has adopted the Securities and Exchange Commission rule allowing companies to furnish proxy materials to their stockholders over the Internet. We believe that this e-proxy process expedites stockholders receipt of proxy materials and lowers the costs and reduces the environmental impact of our annual meeting. On April 4, 2019, we mailed to stockholders a Notice of Internet Availability of Proxy Materials (the Notice) containing instructions on how to access our Proxy Statement and Annual Report and vote by Internet. The Notice contains instructions on how you can (i) receive a paper copy of the Proxy Statement and Annual Report, if you only received a Notice by mail, or (ii) elect to receive your Proxy Statement and Annual Report over the Internet.
The matters scheduled to be considered at the Meeting are (i) to elect directors to serve for the ensuing year and until their successors are elected, (ii) to ratify the selection of PricewaterhouseCoopers LLP as the Companys independent registered public accounting firm for the fiscal year ending December 31, 2019, (iii) to approve, by non-binding vote, executive compensation, and (iv) to consider and act upon any other matters which may properly come before the Meeting or any adjournment thereof. These matters are more fully explained in the Proxy Statement that you are encouraged to read in its entirety.
The Companys Board of Directors values and encourages stockholder participation at the Meeting. It is important that your shares be represented, whether or not you plan to attend the Meeting. Please take a moment to vote on the Internet, by telephone, or, if you receive a paper copy of the Proxy Statement and Annual Report, by signing, dating and returning your proxy card in the envelope provided even if you plan to attend the Meeting.
We hope you will be able to attend the Meeting.
Sincerely, |
Christopher J. OConnell Chairman and Chief Executive Officer |
WATERS CORPORATION
NOTICE OF ANNUAL MEETING OF STOCKHOLDERS
Date: |
Tuesday, May 14, 2019 | |
Time: |
9:00 a.m., local time | |
Place: |
Waters Corporation, 34 Maple Street, Milford, Massachusetts 01757 | |
Record Date: |
March 20, 2019. Only Waters stockholders of record at the close of business on the record date are entitled to receive notice of, and vote at, the annual meeting. | |
Items of Business: |
1. To elect directors to serve for the ensuing year and until their successors are elected; | |
2. To ratify the selection of PricewaterhouseCoopers LLP as the Companys independent registered public accounting firm for the fiscal year ending December 31, 2019; | ||
3. To approve, by non-binding vote, executive compensation; | ||
4. To consider and act upon any other matters which may properly come before the Meeting or any adjournment thereof. | ||
Voting: |
Your vote is extremely important regardless of the number of shares you own. Whether or not you expect to attend the annual meeting in person, we urge you to vote as promptly as possible by telephone or Internet or by signing, dating and returning a printed proxy card or voting instruction form, as applicable. If you attend the annual meeting in person, you may vote your shares during the annual meeting even if you previously voted your proxy. Please vote as soon as possible to ensure that your shares will be represented and counted at the annual meeting. | |
Important Notice Regarding the Availability of Proxy Materials for Annual Meeting of Stockholders
To be Held on May 14, 2019:
The Proxy Statement, Annual Report and the means to vote by Internet are available at http://www.proxydocs.com/wat.
|
By order of the Board of Directors |
|
Mark T. Beaudouin |
Senior Vice President |
General Counsel and Secretary |
Milford, Massachusetts April 4, 2019 |
TABLE OF CONTENTS |
Page | ||||
1 | ||||
6 | ||||
6 | ||||
8 | ||||
8 | ||||
Proposal 2 Ratification of Selection of Independent Registered Public Accounting Firm |
14 | |||
16 | ||||
18 | ||||
19 | ||||
19 | ||||
23 | ||||
24 | ||||
25 | ||||
27 | ||||
28 | ||||
28 | ||||
28 | ||||
31 | ||||
34 | ||||
Report of the Compensation Committee of the Board of Directors |
41 | |||
42 | ||||
50 | ||||
56 | ||||
Security Ownership of Certain Beneficial Owners and Management |
58 | |||
59 | ||||
60 | ||||
60 |
PROXY STATEMENT SUMMARY |
This summary contains highlights about our Company and the upcoming 2019 Annual Meeting of Stockholders, or Annual Meeting. This summary does not contain all of the information that you should consider in advance of the meeting and we encourage you to read the entire proxy statement before voting.
2019 Annual Meeting of Stockholders
| ||
Date: |
Tuesday, May 14, 2019 | |
Time: |
9:00 a.m., local time | |
Place: |
Waters Corporation, 34 Maple Street, Milford, Massachusetts 01757 | |
Record Date: |
March 20, 2019 | |
Mail Date: |
We intend to mail the Notice Regarding the Availability of Proxy Materials, or the proxy statement and proxy card, as applicable, on or about April 4, 2019 to our stockholders. |
Voting Matters and Board Recommendations
| ||||
Matter |
Our Board Recommendation | |||
Proposal 1: |
Election of 10 Nominees to the Board of Directors |
FOR each Director Nominee | ||
Proposal 2: |
Ratification of Selection of Independent Registered Public Accountants |
FOR | ||
Proposal 3: |
Non-Binding Vote to Approve Our Executive Compensation |
FOR |
1
PROXY STATEMENT SUMMARY |
PROPOSAL 1: ELECTION OF 10 NOMINEES TO THE BOARD OF DIRECTORS |
Nominee
|
Age
|
Director Since
|
Independent
|
Financial Expert
|
Audit
|
Compensation
|
Finance
|
Nominating
|
Science
| ||||||||||||||||||||||||||||||||||||
Christopher J. OConnell |
52 | 2015 | No | ||||||||||||||||||||||||||||||||||||||||||
Linda Baddour |
60 | 2018 | Yes | ✓ | M | ||||||||||||||||||||||||||||||||||||||||
Michael J. Berendt, Ph.D. |
70 | 1998 | Yes | ✓ | M | M | |||||||||||||||||||||||||||||||||||||||
Edward Conard |
62 | 1994 | Yes | M | C | ||||||||||||||||||||||||||||||||||||||||
Laurie H. Glimcher, M.D. |
67 | 1998 | Yes | M | C | ||||||||||||||||||||||||||||||||||||||||
Gary E. Hendrickson |
62 | 2018 | Yes | M | |||||||||||||||||||||||||||||||||||||||||
Christopher A. Kuebler |
65 | 2006 | Yes | ✓ | M | C | |||||||||||||||||||||||||||||||||||||||
Flemming Ornskov, M.D., M.P.H. |
61 | 2017 | Yes | M | M | M | |||||||||||||||||||||||||||||||||||||||
JoAnn A. Reed |
63 | 2006 | Yes | ✓ | C | M | |||||||||||||||||||||||||||||||||||||||
Thomas P. Salice |
59 | 1994 | Yes | M | C |
C Chair M Member
Our Board possesses a deep and broad set of skills and experiences that facilitate strong oversight and
strategic direction for a leading global analytical instrument provider.
Skills and Experience
7 Experienced Current and Former CEOs
6 Directors with Scientific Research and/or Healthcare Experience
4 Directors with Financial Expertise within the meaning of the SEC rules and within the meaning of New York Stock Exchange rules
In assessing candidates for Director, the Nominating and Corporate Governance Committee considers their diversity of experience, skills and background in the context of the overall composition of the Board. Our Board is currently comprised of Directors with extensive industry experience and with a broad set of skills critical to providing us with strategic and operational oversight. In addition, our Board is comprised of individuals with a diversity of backgrounds. For example, of our current Directors, seven have served as a chief executive officer, three are women, six have had careers in industries that are relevant to our business, three have technical backgrounds in science and technology, four are experts in finance and capital allocation, two have accounting backgrounds, and two have served as a chief financial officer.
2
PROXY STATEMENT SUMMARY |
CORPORATE GOVERNANCE HIGHLIGHTS
Proxy Access | 90% | LEAD | 6 | 7 | ||||
For Director Nominations |
Independent Directors |
Independent Director |
Scientific Research and/or Healthcare Experience
|
Current and Former CEOs |
✓ Proxy Access
Based on stockholder feedback, we adopted a proxy access bylaw that permits a stockholder who has, or a group of up to 20 stockholders who have, owned at least 3% of the Companys outstanding common stock for at least three years to nominate and include in the Companys proxy materials the greater of two individuals or up to 20% of the number of directors then serving, provided that the nominating stockholder or stockholder group and the nominees satisfy the requirements specified in the Bylaws.
✓ Majority Voting Standard
Our Bylaws provide for a majority voting standard for uncontested director elections.
✓ Independent Board and Committees
9 of our 10 director nominees (all directors except our Chief Executive Officer), and all members of the Audit Committee, Compensation Committee, Finance Committee, Nominating and Corporate Governance Committee and Science and Technology Committee are independent.
✓ Engaged in Strategy
Our Board is engaged in advising and overseeing the Companys strategy and strategic priorities.
✓ Director Qualifications and Evaluations
All Directors meet the candidate qualifications in our Board of Directors Guidelines for Director Qualifications and Evaluations included in this proxy statement.
✓ Lead Independent Director
The independent members of our Board elected Thomas P. Salice as our lead independent director. We have active participation by all directors, including the 9 independent director nominees.
✓ Regular Executive Sessions of Independent Directors
Our independent directors meet privately on a regular basis. Our lead independent director presides at such meetings.
✓ Stock Ownership Requirements
We have robust stock ownership requirements for our directors and officers.
✓ Nominating and Corporate Governance Committee
The Nominating and Corporate Governance Committee is responsible for identifying and recommending to the Board, candidates qualified for membership, and to review the Companys Corporate Governance framework providing advice and recommendations on corporate governance matters.
✓ Enterprise Risk Management
We have an Enterprise Risk Management framework to identify, assess, manage, report and monitor enterprise risk and areas that may affect our ability to achieve our objectives.
THE BOARD OF DIRECTORS RECOMMENDS A VOTE FOR EACH OF THE 10 NAMED NOMINEES |
3
PROXY STATEMENT SUMMARY |
PROPOSAL 2: RATIFICATION OF SELECTION OF INDEPENDENT |
| The Audit Committee of the Board has selected PricewaterhouseCoopers LLP, or PwC, as our independent registered public accountants for the fiscal year ending December 31, 2019. |
| PwC has served as our independent registered public accounting firm since the Companys inception in 1994. |
| Each year, the Audit Committee evaluates the qualifications and performance of the Companys independent registered public accountants and determines whether to re-engage the current independent registered public accountants. |
| Based on this evaluation, the Audit Committee believes that the continued retention of PwC is in the best interests of the Company and its stockholders. |
THE BOARD OF DIRECTORS RECOMMENDS A VOTE FOR THE
RATIFICATION OF THE |
PROPOSAL 3: NON-BINDING VOTE TO APPROVE OUR EXECUTIVE COMPENSATION |
Under the Dodd-Frank Wall Street Reform and Consumer Protection Act (the Dodd-Frank Act), the stockholders of Waters are entitled to cast an advisory vote at the Meeting to approve the compensation of the Companys named executive officers, as disclosed in this proxy statement. Pursuant to the Dodd-Frank Act, the stockholder vote is an advisory vote only and is not binding on Waters or the Board. Stockholders have elected to conduct this vote annually.
Although the vote is non-binding, the Compensation Committee and the Board value your opinions and will consider the outcome of the vote in establishing and evaluating the Companys executive compensation program and making future compensation decisions.
As described more fully in the Compensation Discussion and Analysis, the Summary Compensation Table and the other tables following the Summary Compensation Table, the Companys named executive officers are compensated in a manner consistent with our business strategy, competitive practice and sound compensation governance principles, and with a focus on short- and long-term performance-based and variable compensation.
Please refer to the Compensation Discussion and Analysis for a full description of our executive compensation practices and programs.
We are requesting your non-binding vote on the following resolution:
RESOLVED, that the compensation of the Companys named executive officers as described in the Compensation Discussion and Analysis, in the Summary Compensation Table and subsequent tables, is approved.
Required Vote and Recommendation of the Board of Directors
The affirmative vote of a majority of the shares present or represented by proxy and entitled to vote, is required for approval, on an advisory basis, of this Proposal. If you own shares through a bank, broker or other holder of record, you must instruct your bank, broker or other holder of record how to vote in order for them to vote your shares so that your vote can be counted on this Proposal. Abstentions will have the effect of a vote against this Proposal. Broker non-votes will have no effect on this Proposal.
THE BOARD OF DIRECTORS RECOMMENDS A VOTE FOR THE RESOLUTION. |
4
PROXY STATEMENT SUMMARY |
PROPOSAL 4 - OTHER BUSINESS |
The Board does not know of any other business to be presented at the Meeting. If any other matters properly come before the Meeting, however, it is intended that the persons named in the enclosed form of Proxy will vote said Proxy in accordance with their best judgment.
5
PROXY STATEMENT |
INFORMATION CONCERNING SOLICITATION AND VOTING
SOLICITATION
This Proxy Statement is being furnished by the Board of Directors (the Board) of Waters Corporation (Waters or the Company), in connection with the Boards solicitation of proxies (each a Proxy and, collectively, Proxies), for use at the 2019 Annual Meeting of Stockholders (the Meeting) to be held on May 14, 2019 at 9:00 a.m., local time, at the Companys headquarters located at 34 Maple Street, Milford, Massachusetts 01757. Solicitation of Proxies, which is being made by the Board, may be made through officers and regular employees of the Company by telephone or by oral communications with stockholders following the original solicitation. No additional compensation will be paid to officers or regular employees for such Proxy solicitation. The Company has retained Alliance Advisors, LLC to conduct a broker solicitation for a fee of $9,000, plus reasonable out-of-pocket expenses. Expenses incurred in connection with the solicitation of Proxies will be borne by the Company.
VOTING MATTERS
The representation in person or by Proxy of a majority of the outstanding shares of common stock of the Company, par value $.01 per share, entitled to vote at the Meeting is necessary to provide a quorum for the transaction of business at the Meeting. Shares can only be voted if a stockholder is present in person, has voted via the Internet or by telephone, or is represented by a properly signed Proxy. Each stockholders vote is very important. Whether or not you plan to attend the Meeting in person, please vote over the Internet or by telephone or sign and promptly return the Proxy card, which requires no additional postage if mailed in the United States. All signed and returned Proxies will be counted towards establishing a quorum for the Meeting, regardless of how the shares are voted.
Shares represented by Proxy will be voted in accordance with your instructions. You may specify how you want your shares to be voted by voting on the Internet, by telephone, or by marking the appropriate box on the Proxy card. If your Proxy card is signed and returned without specifying how you want your shares to be voted, your shares will be voted as recommended by the Board, or as the individuals named as Proxy holders deem advisable on all other matters as may properly come before the Meeting. The Proxy will be voted at the Meeting if the signer of the Proxy was a stockholder of record on March 20, 2019 (the Record Date).
Any stockholder voting by Proxy has the power to revoke the Proxy prior to its exercise either by voting by ballot at the Meeting, by executing a later-dated Proxy or by delivering a signed written notice of the revocation to the office of the Secretary of the Company at 34 Maple Street, Milford, Massachusetts 01757 before the Meeting begins.
Representatives of the Companys independent registered public accounting firm, PricewaterhouseCoopers LLP, are expected to be present at the Meeting. They will have the opportunity to make statements if they desire to do so and will be available to respond to appropriate questions.
As of the Record Date, there were 70,757,377 shares of common stock outstanding and entitled to vote at the Meeting. Each outstanding share of common stock is entitled to one vote. There are no cumulative voting rights. This Proxy Statement and form of Proxy is first being made available to the stockholders of record on or about April 4, 2019. A list of the stockholders entitled to vote at the Meeting will be available for inspection at the Meeting and for ten days prior to the Meeting at the Companys headquarters for proper purposes relating to the Meeting.
6
PROXY STATEMENT |
VOTING
To ensure that your vote is recorded promptly, please vote as soon as possible, even if you plan to attend the Meeting in person. Stockholders have three options for submitting their votes: (1) via the Internet, (2) by phone or (3) by mail using a paper proxy card. If you have Internet access, we encourage you to record your vote on the Internet. It is convenient for you, and it saves the Company significant postage and processing costs. In addition, when you vote via the Internet or by telephone prior to the Meeting date, your vote is recorded immediately and there is no risk that postal delays will cause your vote to arrive late and therefore not be counted. Refer to your Notice, or the email you received for electronic delivery of the Proxy Statement for further instructions on voting.
VOTE BY INTERNET |
VOTE BY TELEPHONE |
VOTE BY MAIL | ||
http://www.proxypush.com/wat | 866-307-0858 | Mark, sign, and date the proxy card and return it in the enclosed postage-paid envelope. | ||
24 hours a day/7 days a week | Toll-free 24 hours a day/7 days a week |
|||
Use the Internet to vote your Proxy. Have your proxy card in hand when you access the website. |
Use any touch-tone telephone to vote your Proxy. Have your proxy card in hand when you call. |
If you vote your proxy by Internet or by telephone, please do NOT mail back the proxy card. You can access, view and download this years Proxy Statement and Annual Report at http://www.proxydocs.com/wat.
ELECTRONIC DELIVERY OF WATERS STOCKHOLDER COMMUNICATIONS
Notice of Electronic Availability of Proxy Statement and Annual Report
As permitted by Securities and Exchange Commission (SEC) rules, Waters is making this Proxy Statement and its Annual Report available to its stockholders electronically via the Internet. On April 4, 2019, we mailed to our stockholders a Notice of Internet Availability of Proxy Materials (Notice) containing instructions on how to access this Proxy Statement and our Annual Report and vote by Internet. If you received the Notice by mail, you will not receive a printed copy of the proxy materials in the mail. Instead, the Notice instructs you on how to access and review all of the important information contained in the Proxy Statement and Annual Report electronically or to receive a printed version in the mail. The Notice also instructs you on how you may submit your proxy over the Internet or in person at the Meeting.
Important Notice Regarding Availability of Proxy Materials:
The Proxy Statement and Annual Report are available at http://www.proxydocs.com/wat.
Whether or not you expect to attend the Meeting in person, we urge you to vote your shares by phone, via the Internet, or, if you receive a paper copy of the Proxy Statement and Annual Report, by signing, dating, and returning the proxy card by mail at your earliest convenience. This will ensure the presence of a quorum at the Meeting. Promptly voting your shares will save us the expense and extra work of additional solicitation. Submitting your proxy now will not prevent you from voting your stock at the Meeting if you want to do so, as your vote by proxy is revocable at your option.
7
MATTERS TO BE ACTED UPON |
Ten members of the Board (the Directors) are to be elected at the Meeting, each to hold office until his or her successor is elected and qualified or until his or her earlier resignation, death or removal. It is intended that the Proxies in the form enclosed with this Proxy Statement will be voted for the nominees set forth below unless stockholders specify to the contrary in their Proxies or specifically abstain from voting on this matter.
The following information pertains to the nominees, their ages, principal occupations and other public directorships for at least the last five years, and information regarding their specific experience, qualifications, attributes or skills that led to the conclusion that each such person should serve as a Director of the Company in light of the Companys business and structure.
Nominee
|
Age
|
Director Since
|
Independent
|
Financial Expert
|
Audit
|
Compensation
|
Finance
|
Nominating
|
Science
| ||||||||||||||||||||||||||||||||||||
Christopher J. OConnell |
52 |
2015 |
No |
||||||||||||||||||||||||||||||||||||||||||
Linda Baddour |
60 |
2018 |
Yes |
✓ |
M |
||||||||||||||||||||||||||||||||||||||||
Michael J. Berendt, Ph.D. |
70 |
1998 |
Yes |
✓ |
M |
M | |||||||||||||||||||||||||||||||||||||||
Edward Conard |
62 |
1994 |
Yes |
M |
C |
||||||||||||||||||||||||||||||||||||||||
Laurie H. Glimcher, M.D. |
67 |
1998 |
Yes |
M |
C | ||||||||||||||||||||||||||||||||||||||||
Gary E. Hendrickson |
62 |
2018 |
Yes |
M |
|||||||||||||||||||||||||||||||||||||||||
Christopher A. Kuebler |
65 |
2006 |
Yes |
✓ |
M |
C |
|||||||||||||||||||||||||||||||||||||||
Flemming Ornskov, M.D., M.P.H. |
61 |
2017 |
Yes |
M |
M |
M | |||||||||||||||||||||||||||||||||||||||
JoAnn A. Reed |
63 |
2006 |
Yes |
✓ |
C |
M |
|||||||||||||||||||||||||||||||||||||||
Thomas P. Salice |
59 |
1994 |
Yes |
M |
C |
C Chair M Member
Our Board possesses a deep and broad set of skills and experiences that facilitate strong oversight and strategic direction for a leading global analytical instrument provider.
Skills and Experience
7 Experienced Current and Former CEOs
6 Directors with Scientific Research and/or Healthcare Experience
4 Directors with Financial Expertise within the meaning of the SEC rules and within the meaning of New York Stock Exchange rules
8
MATTERS TO BE ACTED UPON |
Director Skills, Experience and Background
Waters is the worlds leading manufacturer of specialty measurement tools, and primarily designs, manufactures, sells and services instruments that are used by life science, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic and governmental customers working in research and development, quality assurance and other laboratory applications. As we discuss below under Directors Meetings and Board Committees, the Nominating and Corporate Governance Committee, together with the Board, is responsible for assessing the appropriate skills, experience and background that we seek in Board members in the context of our business and the existing composition of the Board. Our Board is currently comprised of Directors with extensive industry experience and with a broad set of skills critical to providing us with strategic and operational oversight. In addition, our board is comprised of individuals with a diversity of backgrounds. For example, of our current Directors, seven have served as a chief executive officer, three are women, six have had careers in industries that are relevant to our business, three have technical backgrounds in science and technology, four are experts in finance and capital allocation, two have accounting backgrounds, and two have served as a chief financial officer.
Christopher J. OConnell
|
Experience: |
Mr. OConnell, 52, has served as a Chairman of the Board and Chief Executive Officer since January 2018. From September 2015 to January 2018, he served as President, Chief Executive Officer and a Director of the Company. From August 2009 to August 2015, Mr. OConnell served as Executive Vice President and President of the Restorative Therapies Group of Medtronic plc. From 1994 to August 2009, Mr. OConnell served in the following positions at Medtronic plc: Senior Vice President and President of Medtronic Diabetes, President of Medtronic Physio-Control, Vice President of Sales and Marketing for the Cardiac Rhythm Management business, Vice President/General Manager of the Patient Management business, Vice President of Corporate Strategy, Director of Investor Relations and Corporate Development Associate. | |
Qualifications: |
Mr. OConnell has over 24 years of progressive leadership positions. Prior to Waters, he provided overall strategic direction and operational management of the Medtronics Restorative Therapies Groups five divisions, as well as led the integration of the Groups activities within the overall strategy of the corporation. | |
Waters Committee Memberships: |
None | |
Other Current Public Company Boards: |
None | |
Former Public Company Directorships Held in the Past Five Years: |
None |
Linda Baddour
|
Experience: |
Ms. Baddour, 60, has served as a Director of the Company since September 2018. From June 2007 to September 2018, Ms. Baddour served as Executive Vice President and Chief Financial Officer of PRA Health Sciences. From May 2002 to May 2007, she was the Chief Financial Officer and Accounting Officer and from 1997 to April 2007 she was the Chief Accounting Officer at Pharmaceutical Product Development, Inc. From 1995 to 1997, Ms. Baddour was the Corporate Controller at Pharmaceutical Product Development, Inc. From 1980 to 1995, she served as Controller of Cooperative Bank for Savings Inc. |
9
MATTERS TO BE ACTED UPON |
Qualifications: |
Ms. Baddours extensive experience as a senior financial executive provides the Waters Board with significant accounting, finance and health care industry expertise. | |
Waters Committee Memberships: |
Audit Committee | |
Other Current Public Company Boards: |
None | |
Former Public Company Directorships Held in the Past Five Years: |
None |
Michael J. Berendt, Ph.D.
|
Experience: |
Dr. Berendt, 70, has served as a Director of the Company since March 1998. Since December 2016, Dr. Berendt has been a life sciences industry consultant. From November 2013 to November 2016, Dr. Berendt was the Chief Executive Officer and Chief Scientist of Telesta Therapeutics. From July 2011 to November 2013, Dr. Berendt was a life sciences industry consultant. From March 2006 to July 2011, Dr. Berendt served as the President and Chief Executive Officer of Aegera Therapeutics Inc. From August 2004 to December 2005, Dr. Berendt served as Managing Director of Research Corporation Technologies, Inc. From November 2000 to August 2004, Dr. Berendt served as Managing Director of AEA Investors LP. Dr. Berendt also worked for 18 years, from 1982 to 2000, in the pharmaceutical industry where he served in a number of senior management positions including Senior Vice President of Research for the Pharmaceutical Division of Bayer Corporation, and a Group Director of Drug Discovery at Pfizer, Inc. | |
Qualifications: |
Dr. Berendts experience in the pharmaceutical industry both from a management and a scientific perspective provides unique technical insight to the Waters Board. In addition, Dr. Berendts years of experience as a Chief Executive Officer and as a senior financial executive, affords the Waters Board the benefit of his financial and business strategy skills. | |
Waters Committee Memberships: |
Audit Committee Science and Technology Committee | |
Other Current Public Company Boards: |
None | |
Former Public Company Directorships Held in the Past Five Years: |
None |
Edward Conard
|
Experience: |
Mr. Conard, 62, has served as a Director of the Company since August 1994. He has been an independent director and investor since January 2008. Mr. Conard was a Managing Director of Bain Capital, LLC from March 1993 to December 2007. Mr. Conard was previously a Director of Wasserstein Perella & Co., Inc., an investment banking firm that specializes in mergers and acquisitions, and a Vice President of Bain & Company heading up the firms operations practice area. |
10
MATTERS TO BE ACTED UPON |
Qualifications: |
Mr. Conards years of experience as a director and a managing director of two large investment firms affords the Waters Board the benefit of his considerable financial, accounting and business strategy skills. | |
Waters Committee Memberships: |
Compensation Committee Finance Committee (Chair) | |
Other Current Public Company Boards: |
None | |
Former Public Company Directorships Held in the Past Five Years: |
None |
Laurie H. Glimcher, M.D.
|
Experience: |
Dr. Glimcher, 67, has served as a Director of the Company since January 1998. Dr. Glimcher is the President and Chief Executive Officer of the Dana-Farber Cancer Institute, the Principal Investigator and Director of the Dana-Farber/Harvard Cancer Center and the Richard and Susan Smith Professor of Medicine, Harvard Medical School. From January 2012 to June 2016, Dr. Glimcher served as the Stephen and Suzanne Weiss Dean of the Weill Cornell Medical College and Provost for Medical Affairs of Cornell University. From 1991 through 2011, Dr. Glimcher served as the Irene Heinz Given Professor of Immunology at the Harvard School of Public Health and Professor of Medicine at Harvard Medical School. | |
Qualifications: |
As a physician, scientist and professor, Dr. Glimcher brings a diversity of technical skills and experience to the Waters Board. She is a Fellow of the American Academy of Arts and Sciences and a member of the National Academy of Sciences and the Institutes of Medicine of the National Academy of Sciences. | |
Waters Committee Memberships: |
Nominating and Corporate Governance Committee Science and Technology Committee (Chair) | |
Other Current Public Company Boards: |
GlaxoSmithKline plc | |
Former Public Company Directorships Held in the Past Five Years: |
Bristol-Myers Squibb Company |
Gary E. Hendrickson
|
Experience: |
Mr. Hendrickson, 62, has served as a Director of the Company since September 2018. He has been an independent director and investor since June 2017. From June 2011 to June 2017, he served as the Chief Executive Officer of The Valspar Corporation; and from June 2012 to June 2017, he also served as the Chairman; and from February 2008 to June 2017, he also served as the President. From February 2001 to June 2008, Mr. Hendrickson served in the following positions of The Valspar Corporation: Chief Operating Officer, Group Vice President of Global Wood Coatings, Senior Vice President of Architectural, Global Wood Coatings and Federal Business Units and Corporate Vice President and President of Asia Pacific. |
11
MATTERS TO BE ACTED UPON |
Qualifications: |
Mr. Hendricksons years of experience as a President, Chief Executive Officer and Chairman affords the Waters Board the benefit of his considerable financial, accounting and business strategy skills. | |
Waters Committee Memberships: |
Compensation Committee | |
Other Current Public Company Boards: |
Polaris Industries Inc. | |
Former Public Company Directorships Held in the Past Five Years: |
The Valspar Corporation |
Christopher A. Kuebler
|
Experience: |
Mr. Kuebler, 65, has served as a Director of the Company since May 2006. He has been an independent director and investor since 2006. He served as Chairman and Chief Executive Officer of Covance Inc. and its predecessor companies from November 1994 to December 2004 and as Chairman during 2005. Prior to joining Covance, Inc., Mr. Kuebler spent nearly 20 years in the pharmaceutical industry at Abbott Laboratories, Squibb, Inc. and the Monsanto Company. | |
Qualifications: |
With 30 years of experience in the pharmaceutical and pharmaceutical service industries, including 10 years as Chairman and Chief Executive Officer of Covance Inc., Mr. Kuebler brings an experienced management perspective to the Waters Board, as well as the expertise in the oversight of financial accounting and business strategy. | |
Waters Committee Memberships: |
Audit Committee Compensation Committee (Chair) | |
Other Current Public Company Boards: |
None | |
Former Public Company Directorships Held in the Past Five Years: |
Nektar Therapeutics |
Flemming Ornskov, M.D., M.P.H.
|
Experience: |
Dr. Ornskov, 61, has served as a Director of the Company since June 2017. From January 8, 2019 to March 31, 2019, Dr. Ornskov served as an advisor to the CEO of Takeda Pharmaceutical Company Ltd. He served as the Chief Executive Officer Designate, as well as Board Member of Shire Plc from January 2, 2013, and as Chief Executive Officer from April 30, 2013 to January 8, 2019. From 2010 to 2012, he served as the Chief Marketing Officer and Global Head of Strategic Marketing for General & Specialty Medicine at Bayer AG. From 2008 to 2010, he served as Global President of Pharmaceuticals and OTC at Bausch & Lomb, Inc. From 2006 to 2008, he also served as the Chairman and later as President and Chief Executive Officer of Life-Cycle Pharma A/S. From 2005 to 2006, he served as President and Chief Executive Officer of Ikaria, Inc. In his pharmaceutical career, he had roles of increasing responsibility at Merck & Co. Inc. and Novartis AG. |
12
MATTERS TO BE ACTED UPON |
Qualifications: |
Dr. Ornskov brings both operational and medical knowledge along with an extensive international, strategic and operational experience in the pharmaceutical sector both at senior leadership and board levels. | |
Waters Committee Memberships: |
Compensation Committee Nominating and Corporate Governance Committee Science and Technology Committee | |
Other Current Public Company Boards: |
Recordati S.p.A. | |
Former Public Company Directorships Held in the Past Five Years: |
Shire plc |
JoAnn A. Reed
|
Experience: |
Ms. Reed, 63, has served as a Director of the Company since May 2006. Ms. Reed has been a health care services consultant since 2009. From April 2008 to April 2009, she was an advisor to the Chief Executive Officer of Medco Health Solutions, Inc. From 2002 to March 2008, Ms. Reed served as Senior Vice President, Finance and Chief Financial Officer of Medco Health Solutions, Inc. From 1992 to 2002, she served as Senior Vice President, Finance of Medco Health Solutions, Inc. She joined Medco Containment Services, Inc. in 1988. Her prior experience includes employment with CBS, Inc., Aetna/American Re-insurance Co., Standard and Poors Financial Services LLC, and Unisys/Timeplex. | |
Qualifications: |
Ms. Reeds extensive experience as a senior financial executive provides the Waters Board with significant accounting, finance and health care industry expertise. | |
Waters Committee Memberships: |
Audit Committee (Chair) Finance Committee | |
Other Current Public Company Boards: |
American Tower Corporation Mallinckrodt PLC | |
Former Public Company Directorships Held in the Past Five Years: |
None |
Thomas P. Salice
|
Experience: |
Mr. Salice, 59, has served as a Director of the Company since July 1994. Mr. Salice is a co-founder and managing member of SFW Capital Partners, LLC, a private equity firm. He has served as a Managing Member of SFW Capital Partners, LLC since January 2005. From June 1989 to December 2004, Mr. Salice served in a variety of capacities with AEA Investors, Inc., including Managing Director, President and Chief Executive Officer and Vice-Chairman. Mr. Salice is Director of several privately held companies: Filtec and Gerson Lehrman Group, Inc. | |
Qualifications: |
With more than 20 years of experience in the private equity business, Mr. Salice brings to the Waters Board in-depth experience in strategic planning, finance, capital structure and mergers and acquisitions. |
13
MATTERS TO BE ACTED UPON |
Waters Committee Memberships: |
Finance Committee Nominating and Corporate Governance Committee (Chair) | |
Other Current Public Company Boards: |
Mettler-Toledo International, Inc. | |
Former Public Company Directorships Held in the Past Five Years: |
None |
Required Vote and Recommendation of the Board of Directors
With respect to the election of Directors of the Company, a nominee for director shall be elected to the Board by a majority vote (i.e., the votes cast for such nominee must exceed the votes cast against such nominee), except that Directors will be elected by plurality vote at any meeting of stockholders for which the number of nominees exceeds the number of directors to be elected (a contested election). If an incumbent director fails to be re-elected by a majority vote when such a vote is required and offers to resign, and if that resignation is not accepted by the Board, such director shall continue to serve until the next annual meeting and until his or her successor is duly elected, or his or her earlier resignation or removal. If an incumbent directors resignation is accepted by the Board, or if a nominee for director is not elected and the nominee is not an incumbent director, then the Board, in its sole discretion, may fill any resulting vacancy or may decrease the size of the Board. Abstentions and shares with respect to which a broker or representative does not vote on a particular matter because it does not have discretionary voting authority on that matter (so-called broker non-votes) are counted as present for the purpose of determining whether a quorum is present. Abstentions and broker non-votes will not be treated as shares cast with respect to any nominee and therefore will not have an effect on the determination of whether a nominee has been elected.
THE BOARD OF DIRECTORS RECOMMENDS A VOTE FOR EACH
NOMINEE FOR
|
The Audit Committee of the Board has selected PricewaterhouseCoopers LLP, or PwC, an independent registered public accounting firm, to audit the books, records and accounts of the Company for the fiscal year ending December 31, 2019. In accordance with a vote of the Audit Committee and as approved by the Board, this selection is being presented to the stockholders for ratification at the Meeting.
Required Vote and Recommendation of the Board of Directors
The affirmative vote of a majority of the shares present at the Meeting in person or represented by Proxy and entitled to vote is required to approve the proposal. Abstentions will be counted as present for the purpose of determining whether a quorum is present and will be treated as shares present and entitled to vote and therefore will have the effect of a vote against the proposal. Ratification by stockholders is not required. Brokerage firms may vote to ratify the appointment of PwC as it is a discretionary or routine item. If this Proposal 2 is not approved by the stockholders, the Audit Committee does not intend to change the appointment for fiscal year 2019, but will consider the stockholder vote in selecting an independent registered public accounting firm for fiscal year 2020.
14
MATTERS TO BE ACTED UPON |
Fees
The aggregate fees for the fiscal years ended December 31, 2018 and December 31, 2017 billed by PwC were as follows:
2018 | 2017 | |||||||
Audit Fees |
$ | 4,549,845 | $ | 4,530,846 | ||||
Audit-Related Fees |
142,728 | 21,004 | ||||||
Tax-Related Fees |
||||||||
Tax Compliance |
392,620 | 569,003 | ||||||
Tax Planning |
916,196 | 291,479 | ||||||
|
|
|
|
|||||
Total Tax-Related Fees |
1,308,816 | 860,482 | ||||||
All Other Fees |
-0- | -0- | ||||||
|
|
|
|
|||||
Total |
$ | 6,001,389 | $ | 5,412,332 |
Audit Fees consists of fees for the audit of the Companys annual financial statements, statutory audits, review of the interim condensed consolidated financial statements included in quarterly reports, assistance with review of documents filed with the SEC, and services that are normally provided by PwC in connection with statutory and regulatory filings or engagements, and attest services, except those not required by statute or regulation.
Audit-Related Fees consists of fees for assurance and related services that are reasonably related to the performance of the audit or review of the Companys consolidated financial statements and are not reported under Audit Fees. These services include employee benefit plan audits, acquisition-related services, attest services not required by statute or regulation, and accounting consultations and reviews for various matters.
Tax-Related Fees consists of fees for tax compliance and planning services. Tax compliance fees include fees for professional services related to international tax compliance and preparation. Tax planning fees consist primarily of fees including but not limited to, the impact of acquisitions, restructurings and changes in regulations.
All Other Fees consists of fees for all permissible services other than those reported above.
The Audit Committee pre-approved 100% of the services listed under the preceding captions Audit Fees, Audit-Related Fees, Tax-Related Fees and All Other Fees. The Audit Committees pre-approval policies and procedures are more fully described in its report set forth in this Proxy Statement.
THE BOARD OF DIRECTORS RECOMMENDS A VOTE FOR THE
RATIFICATION OF THE
|
15
MATTERS TO BE ACTED UPON |
2018 Performance Highlights and Connection to our Executive Compensation Program
The chart below illustrates how Waters emphasizes key performance metrics in our executive compensation program and how these metrics align with our business priorities and performance.
Key Business Priorities |
Compensation Design | Performance Results and Corresponding Compensation | ||||
Organic revenue growth |
Alignment with the Companys strategy to drive organic revenue growth, through the use of a non-GAAP constant currency revenue growth metric under our annual incentive plan, the Management Incentive Plan. This metric had a weight of 25% in 2018. |
2018 Non-GAAP constant currency revenue grew 3.7% to $2,394,418 which was over Waters threshold of 3.3% constant currency revenue growth. | ||||
Operating leverage and earnings growth |
Operating leverage and earnings growth is reinforced with a non-GAAP operating income growth threshold goal and a challenging non-GAAP earnings per share (EPS) growth performance goal under the Management Incentive Plan. This non-GAAP EPS metric had a weight of 75% in 2018 and achievement of a threshold level of the non-GAAP operating income goal was required for any payout to be made under the Management Incentive Plan. |
2018 non-GAAP operating income grew 6.4% over the prior year, exceeding the operating income threshold of 3% growth over the prior year.
Non-GAAP earnings per share grew 12.8% over the prior year, which exceeded Waters target of 10% non-GAAP EPS growth. | ||||
Sustainable stockholder value creation |
Alignment with the long-term interests of our stockholders is achieved through our annual performance-based long-term incentive (LTI) equity program, which includes stock options that vest over a five-year period and performance-based restricted stock units (PSUs) that are earned and vest over a three-year performance period and are based on relative total shareholder return (TSR). Beginning with the annual grant of PSUs made in 2017, the Company implemented a post-vesting holding requirement of two years for the CEO and one year for other executive officers. |
For the three-, five- and ten-year periods ending on December 31, 2018, Waters stock yielded a 40%, 89% and 415% return on $100 investment made on December 31, 2015, December 31, 2013 or December 31, 2008, respectively. |
Listening to our Stockholders
Our stockholders have favorable views of many of the aspects of our executive compensation program, including our emphasis on performance-based components of compensation and the strength of our performance goals. Our stockholders, however, did provide constructive feedback to the Company in certain areas of our executive compensation program. Key changes made to our executive compensation program in response to stockholder feedback include:
| PSUs were incorporated into our LTI grants in 2017 |
| Post-vesting holding periods were implemented for PSU awards |
| Annual LTI grants have been re-oriented around the market median |
| All excise tax gross-up provisions were eliminated from agreements with our named executive officers |
16
MATTERS TO BE ACTED UPON |
Compensation Governance and Pay Practices
Waters maintains strong pay and governance practices as outlined below. A full description of these policies and practices can be found in the discussion below under the respective headings in the section entitled Elements of Executive Compensation.
What We Do
|
What We Dont Do
|
|||||
Robust director and executive officer stock ownership guidelines |
No executive perquisites or supplemental benefits |
|||||
Compensation recoupment policy for cash incentive awards |
No new or legacy excise tax gross-up provisions |
|||||
Market-competitive executive compensation levels |
No option repricing without stockholder consent |
|||||
Annual compensation risk assessment |
No ad-hoc discretionary or guaranteed annual bonus payments for named executive officers |
|||||
Anti-hedging policy |
||||||
Independent compensation consultant |
||||||
Double trigger for accelerated equity vesting upon a change of control |
||||||
Post-vesting holding periods for PSU awards |
Under the Dodd-Frank Wall Street Reform and Consumer Protection Act (the Dodd-Frank Act), the stockholders of Waters are entitled to cast a non-binding vote at the Meeting to approve the compensation of the Companys named executive officers, as disclosed in this proxy statement. Pursuant to the Dodd-Frank Act, the stockholder vote is an advisory vote only and is not binding on Waters or the Board. Stockholders have elected to conduct this vote annually.
Although the vote is non-binding, the Compensation Committee and the Board value your opinions and will consider the outcome of the vote in establishing and evaluating the Companys executive compensation program and making future compensation decisions.
As described more fully in the Compensation Discussion and Analysis, the Summary Compensation Table and the other tables following the Summary Compensation Table, the Companys named executive officers are compensated in a manner consistent with our business strategy, competitive practice and sound compensation governance principles, and with a focus on short- and long-term performance-based compensation.
Please refer to the Compensation Discussion and Analysis for a full description of our executive compensation practices and programs.
We are requesting your non-binding vote on the following resolution:
RESOLVED, that the compensation of the Companys named executive officers as described in the Compensation Discussion and Analysis, in the Summary Compensation Table and subsequent tables, is approved.
17
MATTERS TO BE ACTED UPON |
Required Vote and Recommendation of the Board of Directors
The affirmative vote of a majority of the shares present or represented by Proxy and entitled to vote, is required for approval, on an advisory basis, of this proposal. If you own shares through a bank, broker or other holder of record, you must instruct your bank, broker or other holder of record how to vote in order for them to vote your shares so that your vote can be counted on this proposal. Abstentions will have the effect of a vote against this proposal. Broker non-votes will have no effect on this proposal.
THE BOARD OF DIRECTORS RECOMMENDS A VOTE FOR THE RESOLUTION. |
The Board does not know of any other business to be presented at the Meeting. If any other matters properly come before the Meeting, however, it is intended that the persons named in the enclosed form of Proxy will vote said Proxy in accordance with their best judgment.
18
CORPORATE GOVERNANCE |
20
CORPORATE GOVERNANCE |
21
CORPORATE GOVERNANCE |
22
CORPORATE GOVERNANCE |
23
CORPORATE GOVERNANCE |
24
CORPORATE GOVERNANCE |
25
CORPORATE GOVERNANCE |
26
CORPORATE GOVERNANCE |
Based on the items reported above, on February 25, 2019, the Audit Committee recommended to the Board that the Companys audited financial statements be included in the Companys Annual Report on Form 10-K for the fiscal year ended December 31, 2018 for filing with the SEC. The recommendation was accepted by the Board on the same date.
Ms. JoAnn A. Reed (Chair) Ms. Linda Baddour Dr. Michael Berendt Christopher Kuebler
27
COMPENSATION OF DIRECTORS AND EXECUTIVE OFFICERS |
Pay Mix
Consistent with our performance-based compensation philosophy, variable, performance-based compensation comprises a substantial portion of the target total direct compensation (base salary, target annual incentive award and grant date value of the long-term equity incentive awards) for our named executive officers. For 2018, performance-based compensation (annual incentive award and grant date value of long-term equity incentives, as applicable) represented 88% of the target total direct compensation for Mr. OConnell and 75% for all other named executive officers as a group. The pay mix for Mr. OConnell and all other named executive officers is relatively consistent with the Companys industry peer group described below.
CEO Pay Mix
|
NEO Pay Mix
| |
|
|
(1) | The NEO pay mix does include the Base Salary and Performance-based compensation for Messrs. Carson, Harrington, Kim, and Ms. Buck. The pay mix does not include Mr. Carsons sign-on bonus paid in conjunction with his commencement of employment with us. |
29
COMPENSATION OF DIRECTORS AND EXECUTIVE OFFICERS |
2018 Key Business Priorities and Connection to our Executive Compensation Program
The chart below illustrates how Waters emphasizes key performance metrics in our executive compensation program and how these metrics align with our business priorities and performance.
Key Business Priorities |
Compensation Design | Performance Results and Corresponding Compensation |
||||||
Organic |
Alignment with the Companys strategy to drive organic revenue growth, through the use of a non-GAAP constant currency revenue growth metric under our annual incentive plan, the Management Incentive Plan. This metric had a weight of 25% in 2018. |
2018 Non-GAAP constant currency revenue grew 3.7% to $2,394,418 which was over Waters threshold of 3.3% constant currency revenue growth. |
||||||
Operating |
Operating leverage and earnings growth are reinforced with a non-GAAP operating income growth threshold goal and a challenging non-GAAP earnings per share (EPS) growth performance goal under the Management Incentive Plan. This non-GAAP EPS metric had a weight of 75% in 2018 and achievement of a threshold level of the non-GAAP operating income goal was required for any payout to be made under the Management Incentive Plan. |
2018 non-GAAP operating income grew 6.4% over the prior year, exceeding the operating income threshold of 3% growth over the prior year.
Non-GAAP earnings per share grew 12.8% over the prior year, which exceeded Waters target of 10% non-GAAP EPS growth. |
||||||
Sustainable |
Alignment with the long-term interests of our stockholders is achieved through our annual performance-based long-term incentive equity program, which includes stock options that vest over a five-year period and PSUs that are earned and vest over a three-year performance period and are based on relative TSR. Beginning with the annual grant of PSUs made in 2017, the Company implemented a post-vesting holding requirement of two years for the CEO and one year for other executive officers.
|
For the three-, five- and ten-year periods ending on December 31, 2018, Waters stock yielded a 40%, 89% and 415% return on $100 investment made on December 31, 2015, December 31, 2013 or December 31, 2008, respectively. |
30
COMPENSATION OF DIRECTORS AND EXECUTIVE OFFICERS |
Compensation Governance and Pay Practices
Waters maintains strong pay and governance practices as outlined below. A full description of these policies and practices can be found in the discussion below in the section entitled Elements of Executive Compensation.
What We Do |
What We Dont Do |
|||||
● Robust director and executive officer stock ownership guidelines
|
● No executive perquisites or supplemental benefits
|
|||||
● Compensation recoupment policy for cash incentive awards
|
● No new or legacy excise tax gross-up provisions
|
31
COMPENSATION OF DIRECTORS AND EXECUTIVE OFFICERS |
What We Do |
What We Dont Do |
|||||
● Market-competitive executive compensation levels |
● No option repricing without stockholder consent |
|||||
● Annual compensation risk assessment |
● No ad-hoc discretionary or guaranteed annual bonus payments for named executive officers |
|||||
● Anti-hedging policy |
||||||
● Independent compensation consultant |
||||||
● Double-trigger for accelerated equity vesting upon a change of control |
||||||
● Post-vesting holding periods for PSU awards |
32
COMPENSATION OF DIRECTORS AND EXECUTIVE OFFICERS |
The 2018 industry peer group was comprised of the following companies.
Agilent |
Illumina | |
Bio-Rad Laboratories |
Intuitive Surgical | |
Bruker |
Mettler-Toledo | |
Cooper Companies |
Perkin Elmer | |
Edwards Lifesciences |
ResMed | |
FLIR Systems |
Roper Industries | |
Hologic |
STERIS | |
IDEXX Laboratories |
Teleflex | |
Varian Medical |
33
COMPENSATION OF DIRECTORS AND EXECUTIVE OFFICERS |
Compensation |
Objective |
Target Position to |
2018 Market for Executive Officers (1) | |||||
Base Salary |
To attract and retain senior executives and other key employees. | Generally targeted at or below the 50th percentile.
Actual individual salaries may vary based on an executives performance, tenure, experience and contributions.
|
The overall market position for base salaries in 2018 was at approximately the 45th percentile of the market. | |||||
Annual Incentive |
To motivate senior executive officers to achieve strong financial and operational goals as established by the Compensation Committee at the beginning of the fiscal year. | Target payouts at 100% achievement of performance goals are generally positioned at or slightly above the 50th percentile in order to achieve a target total cash position (base salary plus target annual incentive) that approximates the 50th percentile. Achievement of threshold performance goals is required for any payout.
|
The overall market position for total target cash opportunity (that is, the sum of base salary and target annual incentive) was at approximately the 55th percentile of the market. | |||||
Long-Term Performance- Based Equity Incentive Awards |
To motivate senior executives and other key employees to contribute to the Companys long-term growth of stockholder value and to align compensation with the growth in Waters stock price and achievement of the Companys strategic growth goals. Long-term performance-based equity incentive awards are also designed to assist in the retention of senior executives and key employees.
|
Equity compensation is targeted to be at market median. Actual individual grants are determined based on the executives position, performance, tenure, experience and contributions. | Annual long-term equity incentive awards made on December 10, 2018 were at approximately the 50th percentile of the market. |
(1) | The 2018 market position noted in the above table reflects the analysis completed by Pearl Meyer in the fourth quarter of 2018 based on the market composite data described above. It has been the consistent practice of the Compensation Committee to grant long-term equity incentive compensation to the named executive officers at the Compensation Committee meeting held in December of each year. This Pearl Meyer analysis includes the cash compensation comprised of base salary and target annual incentive bonus for each named executive officer for 2018 and the annual long-term performance-based equity incentive awards granted in December 2018. |
34
COMPENSATION OF DIRECTORS AND EXECUTIVE OFFICERS |
Based on Pearl Meyers market assessment of the overall environment for base salary increases and consistent with our objective of targeting at or below the 50th percentile of market for named executive officers, the Compensation Committee increased base salaries for named executive officers as follows:
Name | 2018
Base Pay Increases | |
Christopher J. OConnell
|
5%
| |
Sherry L. Buck
|
3%
| |
Robert G. Carson
|
N/A
| |
Michael C. Harrington
|
4%
| |
Francis S. Kim
|
6% (promotional increase)
|
35
COMPENSATION OF DIRECTORS AND EXECUTIVE OFFICERS |
A summary of our 2018 Management Incentive Plan payout structure as a percentage of the named executive officers base salary is described in the table below.
2018 Management Incentive Plan
Payout Structure as a Percent of Base Salary(1) | ||||||||
Name | Below Threshold Performance |
Threshold Performance (.25 x Target) |
Target Performance (1.0 x Target) |
Maximum Performance (2.5 x Target) | ||||
Christopher J. OConnell |
0% |
31.25% |
125% |
312.5% | ||||
Sherry L. Buck |
0% |
18.75% |
75% |
187.5% | ||||
Robert G. Carson |
0% |
16.25% |
65% |
162.5% | ||||
Michael C. Harrington |
0% |
18.75% |
75% |
187.5% | ||||
Francis S. Kim |
0% |
16.25% |
65% |
162.5% |
(1) | Payouts are interpolated for performance between threshold, target and maximum levels. |
36
COMPENSATION OF DIRECTORS AND EXECUTIVE OFFICERS |
The performance goals required for payout under the 2018 Management Incentive Plan are outlined in the table below.
2018 Management Incentive Plan Performance Targets | ||||||||
2018 Performance Measures |
Below Threshold Performance |
Threshold Performance |
Target Performance |
Maximum Performance | ||||
2018 Non-GAAP EPS growth over 2017 | <5% | 5% | 10% | 20% | ||||
2018 Revenue growth in constant currency over 2017 |
<3.3% | 3.3% | 6.5% | 13.1% | ||||
2018 Non-GAAP Operating Income growth over 2017 |
<3% | 3% | ||||||
The threshold non-GAAP operating income performance metric must be met in order for there to be a payout under the Management Incentive Plan under either non-GAAP EPS or Revenue measured in constant currency component. |
37
COMPENSATION OF DIRECTORS AND EXECUTIVE OFFICERS |
The following chart represents the target bonus opportunity, the actual bonus achieved as a percentage of base salary and target bonus opportunity and the actual bonus paid for 2018.
2018 Management Incentive Plan Payouts | ||||||||
Name |
Target Bonus of Salary |
Actual Bonus Percentage of Salary |
Actual Percentage of |
Actual Bonus Payout | ||||
Christopher J. OConnell
|
125%
|
144%
|
114.97%
|
$1,358,083
| ||||
Sherry L. Buck
|
75%
|
86%
|
114.97%
|
$ 466,275
| ||||
Robert G. Carson
|
65%
|
75%
|
114.97%
|
$ 287,712
| ||||
Michael C. Harrington
|
75%
|
86%
|
114.97%
|
$ 403,545
| ||||
Francis S. Kim
|
65%
|
75%
|
114.97%
|
$ 257,820
|
38
COMPENSATION OF DIRECTORS AND EXECUTIVE OFFICERS |
In 2018, our named executive officers received the following long-term incentive awards:
Name | 2018 Annual (1) |
2018 Annual (1) |
Promotion (1)(2) |
Promotion (1)(2) |
Sign-On (1)(3) |
Sign-On (1)(3) |
Sign-On (1)(3) | |||||||
Christopher J. OConnell |
$3,850,000 | $1,650,000 | - | - | - | |||||||||
Sherry L. Buck |
$1,120,000 | $480,000 | - | - | ||||||||||
Robert G. Carson |
$700,000 | $300,000 | $835,000 | $240,000 | $275,000 | |||||||||
Michael C. Harrington |
$1,050,000 | $450,000 | - | - | ||||||||||
Francis S. Kim |
$700,000 | $300,000 | $560,000 | $240,000 | - | - |
(1) | The award values in this table differ slightly from the grant date fair values of the awards reported in the Grants of Plan-Based Awards Table and the Summary Compensation Table. The award values in this table are the values awarded by the Committee while the grant date fair value of each award in the Grants of Plan-Based awards Table is the award value for accounting purposes. |
(2) | Award granted to Mr. Kim on February 23, 2018 in connection with his promotion to lead the Companys Global Products Group. Mr. Kims promotional grant was determined based on advice from Pearl Meyer on competitive promotional long-term incentive awards. |
(3) | Awards granted to Mr. Carson on February 23, 2018, in connection with his commencement of employment. Mr. Carsons sign-on awards were made to compensate him for a portion of the equity awards from his former employer that were forfeited as a result of joining Waters. Mr. Carsons annual grants were determined based on advice from Pearl Meyer on competitive long-term incentive awards. |
39
COMPENSATION OF DIRECTORS AND EXECUTIVE OFFICERS |
40
COMPENSATION OF DIRECTORS AND EXECUTIVE OFFICERS |
The Compensation Committee has reviewed and discussed with management the Compensation Discussion and Analysis as required by Item 402(b) of Regulation S-K of the Exchange Act. Based on its review and these discussions, the Compensation Committee recommended to the Board that the Compensation Discussion and Analysis be included in this Proxy Statement.
Christopher A. Kuebler (Chair) Edward Conard Gary E. Hendrickson Flemming Ornskov, M.D., M.P.H.
41
COMPENSATION OF DIRECTORS AND EXECUTIVE OFFICERS |
The table below summarizes the compensation of our named executive officers for the fiscal years ended December 31, 2018 and, if applicable, 2017 and 2016. Compensation is not included in the table below for Ms. Buck or Mr. Carson for fiscal years prior to their hire in 2017 and 2018, respectively, or for Mr. Kim for fiscal years 2016 and 2017 because he was not a named executive officer for such fiscal years, or for any of our named executive officers for any portion of a fiscal year during which they were not employed by us.
Summary Compensation Table
| ||||||||||||||||||||
Name and Principal Position |
Year |
Salary |
Bonus |
Stock |
Option |
Non-Equity |
Change in ($)
|
All Other |
Total ($) | |||||||||||
(b) |
(c) |
(d) |
(e) |
(f) |
(g) |
(h) |
(i) | |||||||||||||
Christopher J. OConnell Chief Executive Officer (a) |
|
2018
|
|
$943,269
|
-
|
$1,649,946
|
$3,849,939
|
$1,358,083
|
-
|
$456,984
|
$8,258,221
| |||||||||
|
2017 |
|
$894,202 |
- |
$1,649,850 |
$3,849,973 |
$1,063,824 |
- |
$142,139 |
$7,599,988 | ||||||||||
|
2016 |
|
$849,750 |
- |
$1,840,312 |
$3,500,018 |
$1,299,954 |
- |
$140,981 |
$7,631,015 | ||||||||||
Sherry L. Buck |
|
2018 |
|
$540,144 |
- |
$479,915 |
$1,119,981 |
$466,275 |
- |
$19,437 |
$2,625,752 | |||||||||
|
2017 |
|
$494,712 |
$300,000 |
$1,117,360 |
$2,203,177 |
$372,338 |
- |
$94,707 |
$4,582,294 | ||||||||||
Robert G. Carson Corporate Development |
|
2018 |
|
$325,769 |
$400,000 |
$814,773 |
$1,534,876 |
$287,712 |
- |
$418,590 |
$3,781,720 | |||||||||
Michael C. Harrington Global Markets |
|
2018 |
|
$467,308 |
- |
$449,968 |
$1,049,955 |
$403,545 |
- |
$48,627 |
$2,419,403 | |||||||||
|
2017 |
|
$448,077 |
- |
$404,838 |
$944,999 |
$319,147 |
$21,367 |
$50,259 |
$2,188,687 | ||||||||||
|
2016 |
|
$395,723 |
- |
$441,593 |
$1,339,955 |
$367,154 |
$13,603 |
$41,393 |
$2,599,421 | ||||||||||
Francis S. Kim Senior Vice President, Global Operations |
|
2018 |
|
$340,188 |
- |
$539,801 |
$1,259,896 |
$257,820 |
- |
$17,436 |
$2,415,141 |
(a) | Mr. OConnell received no additional compensation for his services as a director in 2018, 2017 or 2016. |
(b) | Reflects the base salary earned during 2018 and, if applicable, 2017 and 2016. |
(c) | Reflects the sign-on bonuses paid to Ms. Buck in 2017 and to Mr. Carson in 2018 in conjunction with their respective commencement of employment with us. |
(d) | Reflects the aggregate grant date fair value of PSUs and RSUs granted to the named executive officer in the applicable fiscal year, in each case, computed in accordance with FASB ASC Topic 718, excluding the effect of estimated forfeitures. The grant date fair value of the PSUs was determined based on a Monte Carlo simulation model and was determined based on the probable outcome of the performance conditions associated with such awards. The assumptions used to calculate all of the foregoing amounts are disclosed in Note [13] to the Waters Annual Report on Form 10-K for the fiscal years ended December 31, 2018, 2017 and 2016, as applicable, which are incorporated herein by reference. |
(e) | Reflects the aggregate grant date fair value of non-qualified stock options, computed in accordance with FASB ASC Topic 718, excluding the effect of estimated forfeitures. The assumptions used to calculate these amounts are disclosed in Note [13] to the Waters Annual Reports on Form 10-K for the fiscal years ended December 31, 2018, 2017 and 2016, as applicable, which are incorporated herein by reference. The closing prices of the Companys common stock on the grant dates December 10, 2018, December 5, 2017, and December 9, 2016 were $189.54, $194.26, and $139.51, respectively. In the case of Mr. Carson, the grant date fair value of the stock option award in 2018 includes his sign-on award granted on February 23, 2018 at a closing price of the Companys common stock on the grant date of $208.47. In the case of Mr. Kim, the grant date fair value of the stock option awards in 2018 includes the stock options granted on February 23, |
42
COMPENSATION OF DIRECTORS AND EXECUTIVE OFFICERS |
2018 in connection with his promotion, at a closing price of the Companys common stock on the grant date of $208.47. In the case of Ms. Buck, the grant date fair value of the stock option awards in 2017 includes her sign-on award granted on January 19, 2017 at a closing price of the Companys common stock on the grant date of $141.74. |
(f) | Reflects the annual incentive compensation earned in 2018 and, if applicable, 2017 and 2016 under the Companys Management Incentive Plan. |
(g) | Reflects the change in the annual aggregate estimated present value of accrued retirement benefits from both the frozen Waters Retirement Plan and the frozen Waters Retirement Restoration Plan for 2017 and 2016, as applicable, for Mr. Harrington. With respect to 2018, there was a negative $220,043 change in such annual aggregate estimated pension value for Mr. Harrington due to termination of the Waters Retirement Plan. There were no amounts included in any of those years in respect of above-market or preferential earnings on any non-qualified deferred compensation plan balances. Messrs. OConnell, Carson, Kim and Ms. Buck are not eligible to participate in either of the frozen Waters Retirement Plan or the frozen Waters Retirement Restoration Plan. |
(h) | Reflects the matching contribution made for the benefit of each named executive officer under the Waters 401(k) Restoration Plan, a non-qualified retirement plan, and our 401(k) Plan, a qualified retirement plan, for 2018, 2017 and 2016, as applicable, and the dollar amount of group term life insurance premiums paid by the Company on behalf of each named executive officer during 2018, 2017 and 2016, as applicable. In addition, the amounts for Mr. OConnell, Ms. Buck and Mr. Carson include reimbursements for their respective relocations to Massachusetts in 2016, 2017 and 2018, respectively. A summary of these amounts, including the reimbursement for taxes related to relocation expenses is provided in the chart below: |
Named Executive Officer |
Matching Contributions 401(k) Restoration |
Company Paid Group Term Life Premiums |
Relocation Benefits |
|||||||||||||||||
2018 |
2017 |
2016 |
2018 |
2017 |
2016 |
2018 |
2017 |
2016 |
||||||||||||
Christopher J. OConnell |
$192,492 |
$131,881 |
$67,095 |
$1,440 |
$1,440 |
$1,440 |
$263,052 |
$8,818 |
$72,446 |
|||||||||||
Sherry L. Buck |
$16,500 |
$16,200 |
|
$1,440 |
$1,009 |
|
$1,497 |
$77,498 |
|
|||||||||||
Robert G. Carson |
$16,500 |
|
|
$655 |
|
|
$401,435 |
|
|
|||||||||||
Michael C. Harrington |
$47,187 |
$48,914 |
$40,348 |
$1,440 |
$1,345 |
$1,045 |
|
|
|
|||||||||||
Francis S. Kim |
$16,500 |
|
|
$936 |
|
|
|
|
|
(i) | Reflects the total of compensation elements reported in columns (b) through (h) for 2018 and, if applicable, 2017 and 2016. |
43
COMPENSATION OF DIRECTORS AND EXECUTIVE OFFICERS |
The table below sets forth the range of potential payouts under the Management Incentive Plan (MIP) and the grants of stock options, RSUs and PSUs made to the named executive officers in the last fiscal year.
Grants of Plan-Based Awards Fiscal Year 2018 | ||||||||||||||||||||||||
Name |
Award |
Grant |
Estimated Future Payouts Under
|
Estimated Future Payouts
|
All Other
|
All Other |
Exercise |
Grant | ||||||||||||||||
Threshold |
Target |
Maximum |
Threshold |
Target |
Maximum | |||||||||||||||||||
(b) |
(b) |
(b) |
(c) |
(c) |
(c) |
(d) |
(e) |
(f) |
(g) | |||||||||||||||
Christopher J. OConnell |
Stock |
12/10/2018 |
62,621 |
$189.54 |
$3,849,939 | |||||||||||||||||||
PSU |
12/10/2018 |
348 |
8,705 |
17,410 |
$1,946,786 | |||||||||||||||||||
MIP |
$295,313 |
$1,181,205 |
$2,953,125 |
|||||||||||||||||||||
Sherry L. Buck |
Stock |
12/10/2018 |
18,217 |
$189.54 |
$1,119,981 | |||||||||||||||||||
PSU |
12/10/2018 |
101 |
2,532 |
5,064 |
$569,725 | |||||||||||||||||||
MIP |
$101,391 |
$405,563 |
$1,013,906 |
|||||||||||||||||||||
Robert G. Carson |
Stock |
2/23/2018 |
13,627 |
$208.47 |
$834,926 | |||||||||||||||||||
PSU |
2/23/2018 |
46 |
1,151 |
2,302 |
$295,232 | |||||||||||||||||||
RSU |
2/23/2018 |
1,319 |
$274,972 | |||||||||||||||||||||
Stock |
12/10/2018 |
11,385 |
$189.54 |
$699,950 | ||||||||||||||||||||
PSU |
12/10/2018 |
63 |
1,582 |
3,164 |
$355,966 | |||||||||||||||||||
MIP |
$62,563 |
$250,250 |
$625,625 |
|||||||||||||||||||||
Michael C. Harrington |
Stock |
12/10/2018 |
17,078 |
$189.54 |
$1,049,955 | |||||||||||||||||||
PSU |
12/10/2018 |
95 |
2,374 |
4,748 |
$534,174 | |||||||||||||||||||
MIP |
$87,750 |
$351,000 |
$877,500 |
|||||||||||||||||||||
Francis S. Kim |
Stock |
2/23/2018 |
9,139 |
$208.47 |
$559,947 | |||||||||||||||||||
PSU |
2/23/2018 |
46 |
1,151 |
2,302 |
$295,232 | |||||||||||||||||||
Stock |
12/10/2018 |
11,385 |
$189.54 |
$699,950 | ||||||||||||||||||||
PSU |
12/10/2018 |
63 |
1,582 |
3,164 |
$355,966 | |||||||||||||||||||
MIP |
$56,063 |
$224,250 |
$560,625 |
(b) | Reflects the range of payout under the Companys Management Incentive Plan for threshold, target and maximum performance for 2018. Performance below the threshold would result in no payout under the Management Incentive Plan for 2018. The actual amount of the bonus earned by each named executive officer under the Management Incentive Plan for fiscal 2018 is reported in the Summary Compensation Table. For a description of the Management Incentive Plan, please refer to the section titled Compensation Discussion and Analysis Elements of Executive Compensation Annual Incentive above. |
(c) | Reflects the number of PSUs granted by the Compensation Committee on February 23, 2018 to Messrs. Carson and Kim and on December 10, 2018 to all of our named executive officers, in each case, under the Companys 2012 Equity Incentive Plan. The PSUs are earned if the Companys TSR meets or exceeds a specified level of TSR relative to the TSR for the companies included in the S&P Health Care Index over a three-year performance period, generally subject to continued employment through the vesting date of the award. Amounts in the threshold column reflect the number of PSUs that would be earned if threshold performance were achieved (a TSR percentile rank above the 25th percentile), amounts in the target column (100% of the target award) reflect the number of PSUs that would be earned if target performance were achieved (a TSR percentile rank of 50th percentile) and amounts in the maximum column (200% of the target award) reflect the number of PSUs that would be earned if maximum performance were achieved (a TSR percentile rank of 75% or greater). The number of PSUs earned is interpolated between threshold, target and maximum performance levels. |
44
COMPENSATION OF DIRECTORS AND EXECUTIVE OFFICERS |
(d) | Reflects the number of RSUs granted by the Compensation Committee on February 23, 2018 to Mr. Carson, which vest as to one-third of the RSUs on each of the first, second and third anniversaries of the date of grant, generally subject to his continued employment through the applicable vesting date. |
(e) | Reflects the number of non-qualified stock options granted by the Compensation Committee on February 23, 2018 to Messrs. Carson and Kim and December 10, 2018 to all of our named executive officers. The stock options granted in 2018 vest 20% each year on the first five anniversaries of the date of grant, generally subject to continued employment through the applicable vesting date. |
(f) | Reflects the closing price of a share of our common stock on the grant date of the stock option. |
(g) | Amounts shown in this column, with respect to non-qualified stock options granted in 2018, reflect the aggregate grant date fair value computed in accordance with FASB ASC Topic 718, excluding the effect of estimated forfeitures. Amounts shown in this column, with respect to PSUs, reflect the aggregate grant date fair value, computed in accordance with FASB ASC Topic 718, excluding the effect of estimated forfeitures, based on a Monte Carlo simulation model and were determined based on the probable outcome of the performance conditions associated with the awards. Assuming the maximum level of performance is achieved, the aggregate grant date fair value of the 2018 PSUs is $3,893,572 for Mr. OConnell, $1,139,451 for Ms. Buck, $1,302,395 for Mr. Carson, $1,068,347 for Mr. Harrington, and $1,302,395 for Mr. Kim. Amounts in this column, with respect to RSUs granted to Mr. Carson in 2018, reflect the aggregate grant date fair value, computed in accordance with FASB ASC Topic 718, excluding the effect of estimated forfeitures, and were determined by multiplying the number of shares subject to the award by the closing price of Waters common stock on the date the award was granted. The assumptions used to calculate these amounts are disclosed in Note [13] to the Waters Annual Report on Form 10-K for the fiscal year ended December 31, 2018, which are incorporated herein by reference. |
45
COMPENSATION OF DIRECTORS AND EXECUTIVE OFFICERS |
The table below sets forth the outstanding equity awards held by each of our named executive officers as of December 31, 2018.
Outstanding Equity Awards at Fiscal Year-End 2018
|
||||||||||||||||
Option Awards | Stock Awards | |||||||||||||||
Name |
Number of |
Number of |
Option |
Option |
Number of |
Market |
Equity |
Equity Value of Units or That Have Not | ||||||||
(a) |
(a) |
(a) |
(b) |
(b) |
(c) |
(c) | ||||||||||
Christopher J. OConnell |
46,695 |
31,131 |
$123.55 |
9/8/2025 |
0 |
$0 |
||||||||||
81,358 |
54,239 |
$128.93 |
12/9/2025 |
0 |
$0 |
|||||||||||
37,574 |
56,361 |
$139.51 |
12/9/2026 |
0 |
$0 |
11,505 |
$2,170,418 | |||||||||
14,711 |
58,846 |
$194.26 |
12/5/2027 |
0 |
$0 |
4,586 |
$865,149 | |||||||||
0 |
62,621 |
$189.54 |
12/10/2028 |
0 |
$0 |
348 |
$65,650 | |||||||||
Sherry L. Buck |
5,833 |
23,332 |
$141.74 |
1/19/2027 |
1,411 |
$266,185 |
2,775 |
$523,504 | ||||||||
4,012 |
16,049 |
$194.26 |
12/5/2027 |
0 |
$0 |
1,251 |
$236,001 | |||||||||
0 |
18,217 |
$189.54 |
12/10/2028 |
0 |
$0 |
101 |
$19,054 | |||||||||
Robert G. Carson |
0 |
13,627 |
$208.47 |
2/23/2028 |
1,319 |
$248,829 |
622 |
$117,340 | ||||||||
0 |
11,385 |
$189.54 |
12/10/2028 |
0 |
$0 |
63 |
$11,885 | |||||||||
Michael C. Harrington |
20,000 |
0 |
$98.21 |
12/6/2023 |
0 |
$0 |
||||||||||
22,400 |
5,600 |
$113.36 |
12/11/2024 |
0 |
$0 |
|||||||||||
15,761 |
10,508 |
$128.93 |
12/9/2025 |
0 |
$0 |
|||||||||||
5,247 |
7,872 |
$117.68 |
2/10/2026 |
0 |
$0 |
|||||||||||
9,018 |
13,526 |
$139.51 |
12/9/2026 |
0 |
$0 |
2,761 |
$520,863 | |||||||||
3,611 |
14,444 |
$194.26 |
12/5/2027 |
0 |
$0 |
1,125 |
$212,231 | |||||||||
0 |
17,078 |
$189.54 |
12/10/2028 |
0 |
$0 |
95 |
$17,922 | |||||||||
Francis S. Kim |
913 |
2,738 |
$139.51 |
12/9/2026 |
1,290 |
$243,359 |
||||||||||
0 |
5,887 |
$154.33 |
2/17/2027 |
0 |
$0 |
935 |
$176,388 | |||||||||
0 |
9,139 |
$208.47 |
2/23/2028 |
0 |
$0 |
622 |
$117,340 | |||||||||
0 |
11,385 |
$189.54 |
12/10/2028 |
0 |
$0 |
63 |
$11,885 |
46
COMPENSATION OF DIRECTORS AND EXECUTIVE OFFICERS |
(a) | The expiration date for all non-qualified stock option grants is ten years from the date of grant. All non-qualified stock options vest 20% per year on each of the first, second, third, fourth and fifth anniversaries of the date of grant, generally subject to continued employment through the applicable vesting date. |
(b) | RSUs granted on September 8, 2015, January 19, 2017, and February 23, 2018 to Mr. OConnell, Ms. Buck and Mr. Carson, respectively, vest as to one-third of the RSUs on each of the first, second and third anniversaries of the date of grant, generally subject to continued employment through the applicable vesting date. Dollar amounts included in the column have been determined by multiplying the number of outstanding RSUs by $188.65, which was the closing price of Waters common stock on December 31, 2018. |
(c) | PSUs vest upon certification by the Compensation Committee of the achievement of the performance conditions stated in the award following the end of the three-year performance period on December 31, 2019 (for PSUs granted on December 9, 2016 and January 19, 2017), December 31, 2020 (for PSUs granted on December 5, 2017 and February 23, 2018), and December 31, 2021 (for PSUs granted on December 10, 2018) generally subject to continued employment through that date. Amounts included in this column are the number of PSUs that would be earned based upon performance payout achievement as of December 31, 2018. For PSUs granted on December 9, 2016 and January 19, 2017 this achievement is 107%, for PSUs granted on December 5, 2017 and February 23, 2018 this achievement is 54%, and at threshold performance for PSUs granted on December 10, 2018, multiplied by $188.65, which is the closing price of Waters common stock on December 31, 2018. |
The table below sets forth certain information regarding stock option awards exercised by, and shares of our common stock delivered upon vesting of RSUs to, our named executive officers during the last fiscal year.
Option Exercises and Stock Vested Fiscal Year 2018 |
||||||||
Option Awards | Stock Awards | |||||||
Name | Number of
Securities Acquired on Exercise (#) |
Value Realized Upon ($) |
Number
of Shares (#) |
Value Realized on Vesting ($) | ||||
(a) | (b) | |||||||
Christopher J. OConnell | 0 | $0 | 6,745 | $1,301,043 | ||||
Sherry L. Buck | 0 | $0 | 705 | $148,558 | ||||
Robert G. Carson | 0 | $0 | 0 | $0 | ||||
Michael C. Harrington | 30,000 | $3,228,267 | 2,037 | $394,934 | ||||
Francis S. Kim | 2,383 | $124,305 | 430 | $81,502 |
(a) | Equals the Companys stock price on the exercise date, minus the per share exercise price of the non-qualified stock option, multiplied by the number of shares acquired on exercise. |
(b) | Equals the Companys stock price on the vesting date multiplied by the number of shares acquired on vesting. |
47
COMPENSATION OF DIRECTORS AND EXECUTIVE OFFICERS |
The table below sets forth certain information regarding the present value of the accumulated benefits of our named executive officers under our pension arrangements as of December 31, 2018. The Waters Retirement Plan (Retirement Plan) is a U.S. defined benefit cash balance plan for eligible U.S. employees. The Waters Retirement Restoration Plan (Retirement Restoration Plan) is a U.S. unfunded, non-qualified, defined benefit cash balance plan which provides supplemental retirement benefits out of the general assets of the Company that are otherwise limited due to regulations promulgated by the Internal Revenue Service limiting the amount of compensation that may be taken into account in computing the benefit payable under the Retirement Plan. No amounts were paid to our named executive officers under these plans during 2018. These plans have been frozen to new participants since 2007 and the Retirement Plan was terminated in 2018. As part of the plan termination, Mr. Harringtons benefit was transferred to Principal Life Insurance Company.
Pension Benefits Fiscal Year 2018 | ||||||||
Name | Plan Name | Number of Years of Credited Service (#) |
Present Value of Accumulated Benefits ($) |
Payments During Last Fiscal Year ($) | ||||
(b) | (c) | |||||||
Christopher J. OConnell (a) |
Waters Corporation Retirement Plan |
0.00 | $0 | - | ||||
Waters Corporation Retirement Restoration Plan |
0.00 | $0 | - | |||||
Sherry L. Buck (a) |
Waters Corporation Retirement Plan |
0.00 | $0 | |||||
Waters Corporation Retirement Restoration Plan |
0.00 | $0 | ||||||
Robert G. Carson |
Waters Corporation Retirement Plan |
0.00 | $0 | |||||
Waters Corporation Retirement Restoration Plan |
0.00 | $0 | ||||||
Michael C. Harrington |
Waters Corporation Retirement Plan |
31.08 | $0 | - | ||||
Waters Corporation Retirement Restoration Plan |
31.08 | $22,446 | - | |||||
Francis S. Kim |
Waters Corporation Retirement Plan |
0.00 | $0 | |||||
Waters Corporation Retirement Restoration Plan |
0.00 | $0 |
(a) | Messrs. OConnell, Carson, and Kim and Ms. Buck are not eligible to participate in the Waters Retirement Plan or the Waters Retirement Restoration Plan because such plans were frozen in 2007, prior to their hires. |
(b) | The Waters Retirement Plan and the Waters Retirement Restoration Plan were frozen in 2007 and the Waters Retirement Plan was terminated in 2018. |
(c) | The present value of the accumulated benefit is calculated in accordance with FASB Accounting Standards Codification Topic 715 Compensation Retirement Benefits. The Companys valuation methods and assumptions made in connection with the valuation of this accumulated benefit are disclosed in Note 16 to the Waters 2018 Annual Report on Form 10-K for the fiscal year ended December 31, 2018, which are incorporated herein by reference. |
48
COMPENSATION OF DIRECTORS AND EXECUTIVE OFFICERS |
Mr. Harringtons benefits under the Retirement Plan and Retirement Restoration Plan are determined based on annual pay credits and interest credits that are made to each participants notional accounts. Effective December 31, 2007, future pay credits to the Retirement Plan and Retirement Restoration Plan on behalf of senior executives were discontinued. Interest credits will continue to be made to participants notional accounts under the Retirement Restoration Plan and were made under the Retirement Plan prior to its termination. Interest credits are based on the one-year constant maturity Treasury Bill rate on the first business day in November of the preceding plan year plus 0.5%, subject to a 5.0% minimum and a 10.0% maximum rate.
A participant becomes vested in his or her notional account under the Retirement Restoration Plan upon completion of five years of service, at which time the participant becomes 100% vested. The normal retirement age under the Retirement Restoration Plan is age 65 and early retirement is defined as attainment of age 62 with at least 10 years of service (except for former participants of the Millipore Retirement Plan (a former parent company of Waters), who are eligible for early retirement upon attainment of age 55 with at least 10 years of service). Prior to its termination in 2018, these same vesting and retirement provisions applied to the Retirement Plan. Mr. Harrington is the only named executive officer who participated in these plans during 2018, and he was not eligible for retirement or early retirement under these plans in 2018.
The valuation method and material assumptions used in calculating the benefits reported in column (c) are disclosed in the Waters 2018 Annual Report for the fiscal year ended December 31, 2018 and are incorporated herein by reference.
The table below summarizes non-qualified deferred compensation plan benefits in the last fiscal year for our named executive officers.
Non-Qualified Deferred Compensation
| ||||||||||
Name |
Executive Contributions in Last FY ($) |
Registrant Contributions in Last FY ($) |
Aggregate Earnings in Last FY ($) |
Aggregate Withdrawals/ Distributions ($) |
Aggregate Balance at Last FYE ($) | |||||
(a) |
(b) |
(c) |
(d) | |||||||
Christopher J. OConnell |
$448,582 |
$175,992 |
($114,714) |
$0 |
$1,225,153 | |||||
Sherry L. Buck |
$0 |
$0 |
$0 |
$0 |
$0 | |||||
Robert G. Carson |
$0 |
$0 |
$0 |
$0 |
$0 | |||||
Michael C. Harrington |
$253,035 |
$30,687 |
($87,663) |
$0 |
$1,303,998 | |||||
Francis S. Kim |
$0 |
$0 |
$0 |
$0 |
$0 |
(a) | Amounts in this column are also reported as salary (column (b)) or non-equity incentive compensation (column (f)) in the Summary Compensation Table. |
(b) | Amounts in this column represent Company contributions to the 401(k) Restoration Plan. These amounts are also reported under the All Other Compensation column (column (h)) in the Summary Compensation Table. |
(c) | Amounts reported in this column reflect participant-directed earnings in investment vehicles that are consistent with those offered under the qualified 401(k) Plan, with the exception of Waters common stock, the self-directed Brokeragelink Option and the Fidelity Managed Income Portfolio. These amounts are not included in the Summary Compensation Table because the earnings are not above-market or preferential. |
(d) | The aggregate balance amounts under the 401(k) Restoration Plan include deferrals made for prior fiscal years. For individuals who were named executive officers in the fiscal years in which the deferrals were made, the amount of the deferred compensation was included in such individuals compensation as reported in the Summary Compensation Table included in the proxy statement for the applicable fiscal year. |
All non-qualified deferred compensation contributions made by the named executive officers, or by the Company on behalf of the named executive officers, are made under the 401(k) Restoration Plan. The purpose of
49
COMPENSATION OF DIRECTORS AND EXECUTIVE OFFICERS |
the 401(k) Restoration Plan is to allow certain management and highly compensated employees to defer salary, commissions and Management Incentive Plan payments to a non-qualified retirement plan in addition to the amount permitted to be deferred under the 401(k) Plan ($18,500 in 2018, or $24,500 if age 50 or older). The 401(k) Restoration Plan is also intended to permit participants to receive the additional matching contributions that they would have been eligible to receive under the 401(k) Plan if the Internal Revenue Service limits on compensation for such plan ($275,000 in 2018) did not apply. Upon termination of employment or retirement from the Company, account balances are distributed according to the payment option and form of payment (e.g., lump sum or installment payments) elected by the participant at time of deferral.
50
COMPENSATION OF DIRECTORS AND EXECUTIVE OFFICERS |
51
COMPENSATION OF DIRECTORS AND EXECUTIVE OFFICERS |
Potential Post-Termination Payments Table
The following table and footnotes present potential payments to each named executive officer under various circumstances as if the officers employment had been terminated on December 31, 2018, the last business day of fiscal 2018, and, as indicated below, if a change of control had also occurred on such date.
Potential Post Termination Payments Table
| ||||||||||||||||
Name |
Termination/ |
Base Salary
|
Incentive Plan |
Benefits Continuation |
Accelerated (c) |
Accelerated |
Accelerated |
Total Value
| ||||||||
Christopher J. OConnell | Involuntary Termination by the Company without Cause or by the Executive for Good Reason | $1,886,538(a) | $2,358,173(a) | $43,824(a) | $2,026,628 | - | - | $6,315,163 | ||||||||
Death | - | - | - | $8,035,361 | - | $1,886,311 | $9,921,672 | |||||||||
Disability | - | - | - | $2,026,628 | - | - | $2,026,628 | |||||||||
Involuntary Termination by the Company without Cause or by Executive for Good Reason Following Change of Control | $2,829,807(b) | $3,537,259(b) | $65,880(b) | $8,035,361 | - | $5,272,768 | $19,741,075 |
52
COMPENSATION OF DIRECTORS AND EXECUTIVE OFFICERS |
Potential Post Termination Payments Table | ||||||||||||||||
Name |
Termination/ |
Base Salary
|
Incentive Plan |
Benefits Continuation |
Accelerated (c) |
Accelerated |
Accelerated |
Total Value
| ||||||||
Sherry L. Buck |
Involuntary Termination by the Company without Cause or by the Executive for Good Reason | $540,144(a) | $405,108(a) | $21,912(a) | - | - | - | $967,164 | ||||||||
Death | - | - | - | $1,094,504 | $266,185 | $471,752 | $1,832,441 | |||||||||
Involuntary Termination by the Company without Cause or by Executive for Good Reason Following Change of Control | $1,080,289(b) | $810,216(b) | $43,824(b) | $1,094,504 | $266,185 | $1,403,745 | $4,698,763 | |||||||||
Robert G. Carson | Involuntary Termination by the Company without Cause or by the Executive for Good Reason | - | - | - | - | - | - | - | ||||||||
Death | - | - | - | - | $248,829 | $72,442 | $321,271 | |||||||||
Involuntary Termination by the Company without Cause or by Executive for Good Reason Following Change of Control | $651,538(b) | $423,500(b) | $41,842(b) | - | $248,829 | $515,580 | $1,881,289 |
53
COMPENSATION OF DIRECTORS AND EXECUTIVE OFFICERS |
Potential Post Termination Payments Table | ||||||||||||||||
Name |
Termination/ |
Base Salary
|
Incentive Plan |
Benefits Continuation |
Accelerated (c) |
Accelerated |
Accelerated |
Total Value
| ||||||||
Michael C. Harrington | Involuntary Termination by the Company without Cause or by the Executive for Good Reason | - | - | - | - | - | - | - | ||||||||
Death | - | - | - | $2,272,505 | - | $455,590 | $2,728,095 | |||||||||
Involuntary Termination by the Company without Cause or by Executive for Good Reason Following Change of Control | $934,616(b) | $700,962(b) | $31,082(b) | $2,272,505(f) | - | $1,711,999 | $5,651,164 | |||||||||
Francis S. Kim | Involuntary Termination by the Company without Cause or by the Executive for Good Reason | - | - | - | - | - | - | - | ||||||||
Death | - | - | - | $336,587 | $243,359 | $182,425 | $762,371 | |||||||||
Involuntary Termination by the Company without Cause or by Executive for Good Reason Following Change of Control | $680,376(b) | $442,244(b) | $42,724(b) | $336,587 | - | $923,819 | $2,425,750 |
Potential Post-Termination Payments Table
The following table and footnotes present potential payments to each named executive officer under various circumstances as if the officers employment had been terminated on December 31, 2018, the last business day of fiscal 2018, and, as indicated below, if a change of control had also occurred on such date.
(a) | Represents two times annual base salary, target annual incentive bonus award and the value of 24 months of benefits continuation for Mr. OConnell and one times annual base salary, target incentive and the value of 12 months of benefits continuation for Ms. Buck, in each case, determined based on base salary and premium costs, as applicable, as in effect on December 31, 2018. |
(b) | Represents three times annual base salary, target annual incentive bonus and the value of 36 months of benefits continuation for Mr. OConnell, and two times annual base salary, target annual incentive bonus |
54
COMPENSATION OF DIRECTORS AND EXECUTIVE OFFICERS |
and the value of 24 months of benefits continuation for each of Messrs. Carson, Harrington, and Kim and Ms. Buck, in each case, determined based on base salary and premium costs, as applicable, as in effect of December 31, 2018. |
(c) | Represents the in-the-money value of 100% of the unvested portion of the executives stock options upon termination as it relates to Change in Control or Death. For Mr. OConnell, in the event of an involuntary termination by the Company without cause or by the executive for good reason, represents the in-the-money stock option values for his sign-on awards only. The in-the-money stock option value is calculated by multiplying the number of stock options that would have vested upon such employment termination or change of control, as applicable, by the difference between $188.65, the closing price of our common stock on December 31, 2018, and the applicable per share exercise prices of such stock options. |
(d) | Represents 100% of the unvested portion of the executives RSUs. The value of RSUs is calculated by multiplying the number of RSUs that would have vested upon such employment termination or change of control, as applicable, by $188.65, the closing price of our common stock on December 31, 2018. |
(e) | Represents the value of the unvested PSUs assuming the target number of shares vested and became earned on December 31, 2018. The value of the PSUs is calculated by multiplying the target number of units that would have become earned and vested upon such employment termination by $188.65, the closing price of our common stock on December 31, 2018, prorated for the number of days within the performance period as of December 31, 2018, in the case of a termination due to death. The actual amount that can be earned in respect of PSUs will be dependent on actual performance measured at the end of the performance period. |
(f) | Represents the in-the-money value of the stock options granted to Mr. Harrington prior to December 9, 2016. For stock options granted prior to December 9, 2016, in the event of a change of control, all outstanding and unvested stock options would vest in full. The in-the-money value is based on the closing price of our common stock on December 31,2018 ($188.65). |
55
COMPENSATION OF DIRECTORS AND EXECUTIVE OFFICERS |
The table below summarizes the compensation for the Companys non-employee directors in the last fiscal year. Mr. OConnell did not receive any compensation for his service as a director during 2018. The compensation he received in respect of his employment is included in the Summary Compensation Table above.
Director Compensation Fiscal Year
2018
| ||||||||
Name | Fees Earned or
|
Stock Awards ($) | Option Awards ($) | Total ($) | ||||
(a) | (b) | (b) | (c) | |||||
Linda Baddour |
$24,333 | $54,972 | $54,981 | $134,286 | ||||
Michael J. Berendt, Ph.D. |
$78,000 | $109,978 | $109,995 | $297,973 | ||||
Edward Conard |
$95,000 | $109,978 | $109,995 | $314,973 | ||||
Laurie H. Glimcher, M.D. |
$70,000 | $109,978 | $109,995 | $289,973 | ||||
Gary E. Hendrickson |
$22,833 | $54,972 | $54,981 | $132,786 | ||||
Christopher A. Kuebler |
$87,500 | $109,978 | $109,995 | $307,473 | ||||
Flemming Ornskov, M.D, M.P.H. |
$74,500 | $109,978 | $109,995 | $294,473 | ||||
JoAnn A. Reed |
$100,000 | $109,978 | $109,995 | $319,973 | ||||
Thomas P. Salice |
$116,500 | $109,978 | $109,995 | $336,473 |
(a) | Reflects Board and committee retainers and meeting fees earned in 2018. |
(b) | Messrs. Berendt, Conard, Kuebler, Ornskov and Salice, and Mss. Glimcher and Reed were each granted 562 shares of restricted stock on January 2, 2018, with a grant date fair value of $195.69 per share (which reflects the closing price of the Companys common stock on the date of grant) and a vesting date of January 3, 2019. In conjunction with appointment to the Board of Directors, Mr. Hendrickson and Ms. Baddour received 292 shares of restricted stock on September 4, 2018 with a grant date fair value of $188.26. Each of these restricted share grants, was outstanding and held by the directors on December 31, 2018. |
(c) | Our non-employee directors were each granted 2,692 non-qualified stock options on January 2, 2018, with an exercise price of $195.69 (which was the closing price of the Companys common stock on the date of grant), and a vesting date of January 2, 2019. The amount set forth in this column reflects the aggregate grant date fair value of non-qualified stock options, computed in accordance with FASB ASC Topic 718, disregarding the effect of estimate forfeitures. The assumptions used to calculate these amounts are |
56
COMPENSATION OF DIRECTORS AND EXECUTIVE OFFICERS |
disclosed in the footnotes to the Waters Annual Reports on Form 10-K for the fiscal year ended December 31, 2018, which are incorporated herein by reference. In conjunction with appointment to the Board of Directors, Mr. Hendrickson and Ms. Baddour, as non-employee directors, were granted 1,249 non-qualified stock options on September 4, 2018, with an exercise price of $188.26 (which was the closing price of the Companys common stock on the date of grant), and a vesting date of September 4, 2019. The outstanding stock options held by Messrs. Berendt, Conard, Hendrickson, Kuebler, Ornskov and Salice, and Mss. Baddour, Glimcher and Reed on December 31, 2018, were 37,579, 34,079, 1,249, 22,079, 5,734, 34,079, 1,249, 18,079, and 37,579 options, respectively. |
57
The table below sets forth certain information regarding beneficial ownership of common stock as of March 20,2019 by each person or entity known to the Company who owns beneficially five percent or more of the common stock, by each named executive officer and Director nominee and all executive officers and Director Nominees as a group.
Name of Beneficial Owner | Amount and Nature of Beneficial Ownership(1) |
Percentage of Outstanding Common Stock(1) | ||||||||
5% Stockholders |
||||||||||
The Vanguard Group, Inc. (2) |
7,717,305 | 10.9 | % | |||||||
BlackRock, Inc. (3) |
5,577,780 | 7.9 | % | |||||||
Massachusetts Financial Services Company (4) |
4,920,469 | 7.0 | % | |||||||
The Bank of New York Mellon Corporation (5) |
4,413,309 | 6.2 | % | |||||||
Executive Officers and Directors |
||||||||||
Christopher J. OConnell (6) |
199,654 | * | ||||||||
Sherry L. Buck (6) |
17,316 | * | ||||||||
Robert G. Carson |
1,174 | * | ||||||||
Michael C. Harrington (6) |
36,261 | * | ||||||||
Francis S. Kim (6) |
5,464 | * | ||||||||
Linda Baddour |
891 | * | ||||||||
Michael J. Berendt, Ph.D. (6) |
55,589 | * | ||||||||
Edward Conard (6)(8) |
98,589 | * | ||||||||
Laurie H. Glimcher, M.D.(6) |
23,879 | * | ||||||||
Gary E. Hendrickson |
891 | * | ||||||||
Christopher A. Kuebler (6)(8) |
37,589 | * | ||||||||
Flemming Ornskov, M.D., M.P.H. (6)(8) |
7,489 | * | ||||||||
JoAnn A. Reed (6) |
55,402 | * | ||||||||
Thomas P. Salice (6)(7)(8) |
130,687 | * | ||||||||
All Directors and Executive Officers as a group (18 persons) |
805,113 | * |
* | Represents less than 1% of the total number of the issued and outstanding shares of common stock. |
(1) | Figures are based upon 70,757,377 of common stock outstanding as of March 20, 2019. The figures assume exercise by only the stockholder or group named in each row of all options for the purchase of common stock held by such stockholder or group which are exercisable within 60 days of March 20, 2019. The Directors and Executive Officers included in the group are those who were serving such roles on March 20, 2019. |
(2) | Amounts shown reflect the aggregate number of shares of common stock beneficially owned by The Vanguard Group, Inc. based on information set forth in Schedule 13G filed with the SEC on February 11, 2019. The Schedule 13G indicates that the Vanguard Group, Inc. was the beneficial owner with sole dispositive power as to 7,608,897 shares, shared dispositive power as to the 108,408 shares, sole voting power as to 92,804 shares and shared voting power as to 17,227 of the shares. The address of The Vanguard Group, Inc. is 100 Vanguard Boulevard, Malvern, PA 19355. |
(3) | Amounts shown reflect the aggregate number of shares of common stock beneficially owned by BlackRock, Inc. based on information set forth in Schedule 13G filed with the SEC on February 6, 2019. The Schedule 13G indicates that Blackrock, Inc. was the beneficial owner with sole dispositive power as to 5,577,780 shares, with shared dispositive power as to none of the shares, with sole voting |
58
power as to 4,872,056 shares and shared voting power as to none of the shares. The address of BlackRock, Inc. is 40 East 52nd Street, New York, NY 10022. |
(4) | Amounts shown reflect the aggregate number of shares of common stock beneficially owned by Massachusetts Financial Services Company (MFS) based on information set forth in Schedule 13G filed with the SEC on February 13, 2019. The Schedule 13G indicates that MFS was the beneficial owner with sole dispositive power as to 4,920,469 shares, with shared dispositive power as to none of the shares, with sole voting power as to 4,211,444 shares and shared voting power as to none of the shares. The address of MFS is 111 Huntington Ave, Boston, MA 02199. |
(5) | Amounts shown reflect the aggregate number of shares of common stock beneficially owned by The Bank of New York Mellon Corporation based on information set forth in Schedule 13G filed with the SEC on February 4, 2019. The Schedule 13G indicates that (i) The Bank of New York Mellon Corporation was the beneficial owner with sole dispositive power as to 3,528,688 shares, with shared dispositive power as to 884,618 shares, with sole voting power as to 3,689,272 shares and shared voting power as to 235 shares; (ii) BNY Mellon IHC, LLC was the beneficial owner with sole dispositive power as to 3,189,365 shares, with shared dispositive power as to 861,467 shares, with sole voting power as to 3,279,879 shares and shared voting power as none of the shares; and (iii) MBC Investments Corporation was the beneficial owner with sole dispositive power as to 3,189,365 shares, with shared dispositive power as to 861,467 shares, with sole voting power as to 3,279,879 shares and shared voting power as to none of the shares. The address of The Bank of New York Mellon Corporation, BNY Mellon IHC, LLC and MBC Investments Corporation is 240 Greenwich Street, New York, New York 10286. |
(6) | Includes share amounts which the named individuals have the right to acquire through the exercise of options which are exercisable within 60 days of March 20, 2019 as follows: Mr. OConnell 180,338, Ms. Buck 15,656, Mr. Harrington 36,261, Mr. Kim 3,299, Dr. Berendt 34,079, Mr. Conard 34,079, Dr. Glimcher 18,079, Mr. Kuebler 22,079, Dr. Ornskov 5,734, Ms. Reed 34,079 and Mr. Salice 32,079. |
(7) | Includes 3,000 shares held in Mr. Salices Individual Retirement Account, 7,950 shares held by a charitable trust over which Mr. Salice shares voting and investment power with his spouse as trustees and 69,648 shares held by an LLC over which Mr. Salice has voting and investment power. Mr. Salice disclaims beneficial ownership of the shares held by the charitable trust and of the shares held by the LLC, except to the extent of his pecuniary interest in the LLC. |
(8) | Excludes deferred compensation in the form of phantom stock, receipt of which may be, at the election of the Director, on a specified date at least six months in the future or upon his or her cessation of service as a Director of the Company. |
59
We will undertake to deliver promptly upon written or oral request a separate copy our Annual Report, the Proxy Statement or Notice to any stockholder at a shared address to which a single copy of either of those documents was delivered. To receive a separate copy of our Annual Report, Proxy Statement or Notice, or if two stockholders sharing an address have received two copies of any of these documents and desire to only receive one in the future, you may write to the Vice President of Investor Relations at our principal executive offices at 34 Maple Street, Milford, Massachusetts 01757 or call the Vice President of Investor Relations of Waters at (508) 482-2314.
60